• Raia Drogasil’s board met virtually on Nov. 3, 2026, with all directors participating.
• Directors unanimously approved, without reservations, quarterly financial statements for the period ended Sept. 30, 2026, following the audit committee’s recommendation.
• Management was authorized to publish the statements and submit the information to securities regulator CVM and B3.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Raia Drogasil SA published the original content used to generate this news brief on November 03, 2026, and is solely responsible for the information contained therein.